Ads

 

Ads

 

Ads

 

World Top 100 Biopharmaceutical Companies List by Market Cap in January 2024

World Top 100 Biopharmaceutical Companies List by Market Cap in January 2024, World Biggest 100 Biopharmaceutical Companies by Market Cap, World Largest 100 Biopharmaceutical Companies in the World by market cap as pf Jan-05-2024.

Metatag Title
World Top Biopharmaceutical Companies 2024
Metatag Abstract
World Largest Biopharmaceutical Companies by Market Cap in 2024, World Top Biopharmaceutical Companies by Market Cap in 2024.
  1. Biocon

    World Rank (Jan-05-2024)
    3,442
    Market Cap (Jan-05-2024)
    4.090 Billion USD
    World Rank (Jul-30-2023)
    3,712
    Market Cap (Jul-30-2023)
    3.746 Billion USD
    World Rank (Dec-25-2022)
    3,398
    Market Cap (Dec-25-2022)
    3.845 Billion USD
    World Rank (Jan-07-2022)
    2,935
    Market Cap (Jan-07-2022)
    5.76 Billion USD
    Annual Revenue in USD
    1,004 Million USD
    Annual Net Income in USD
    81 Million USD
    Annual Results for Period Ending
    Mar-2022 ending year
    Headquarters Country
    Stock Category
    Company Profile

    Biocon is India's largest Bio-pharmaceutical company with headquarters is in Bangalore, India. As on 2020, it has 12,000 employees and 1220 patents and 900 Registered Trademarks and they supply their products to 120 countries.

    Key therapeutic areas are diabetes, oncology, immunology, agriculture of innovation.

  2. Ultragenyx Pharmaceutical

    World Rank (Jan-05-2024)
    3,549
    Market Cap (Jan-05-2024)
    3.941 Billion USD
    World Rank (Jul-30-2023)
    4,303
    Market Cap (Jul-30-2023)
    3.053 Billion USD
    World Rank (Dec-25-2022)
    4,035
    Market Cap (Dec-25-2022)
    3.051 Billion USD
    World Rank (Jan-07-2022)
    3,267
    Market Cap (Jan-07-2022)
    5.03 Billion USD
    Annual Revenue in USD
    363 Million USD
    Annual Operating Income in USD
    -648 Million USD
    Annual Net Income in USD
    -707 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile

    Ultragenyx Pharmaceutical is a Clinical Stage Biopharmaceutical company. It committed to bringing to patients novel products for the treatment of rare and ultra rare diseases with a focus on serious debilitating genetic diseases. The company portfolio of approved therapies and product candidates aimed at addressing diseases with high unmet medical need and clear biology for which there are no approved therapies. The headquarters is in USA.

  3. Axsome Therapeutics Inc

    World Rank (Jan-05-2024)
    3,583
    Market Cap (Jan-05-2024)
    3.880 Billion USD
    World Rank (Jul-30-2023)
    6,099
    Market Cap (Jul-30-2023)
    1.818 Billion USD
    World Rank (Dec-25-2022)
    5,910
    Market Cap (Dec-25-2022)
    1.753 Billion USD
    Headquarters Country
    Company Profile
    AXSOME THERAPEUTICS INC is a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The headquarters is in USA.
  4. Pharmaessentia Corporation

    World Rank (Jan-05-2024)
    3,704
    Market Cap (Jan-05-2024)
    3.726 Billion USD
    World Rank (Jul-30-2023)
    3,671
    Market Cap (Jul-30-2023)
    3.797 Billion USD
    World Rank (Dec-25-2022)
    2,835
    Market Cap (Dec-25-2022)
    4.782 Billion USD
    World Rank (Jan-07-2022)
    5,518
    Market Cap (Jan-07-2022)
    2.47 Billion USD
    Headquarters Country
    Company Profile
    PHARMAESSENTIA CORPORATION is a fully integrated global biopharmaceutical company delivering efficacious, safe and cost effective therapeutic products for the treatment of human diseases. The headquarters is in China.
  5. Arrowhead Pharmaceuticals

    World Rank (Jan-05-2024)
    3,718
    Market Cap (Jan-05-2024)
    3.710 Billion USD
    World Rank (Jul-30-2023)
    3,705
    Market Cap (Jul-30-2023)
    3.755 Billion USD
    World Rank (Dec-25-2022)
    3,059
    Market Cap (Dec-25-2022)
    4.359 Billion USD
    World Rank (Jan-07-2022)
    2,778
    Market Cap (Jan-07-2022)
    6.16 Billion USD
    Annual Revenue in USD
    243 Million USD
    Annual Operating Income in USD
    -178 Million USD
    Annual Net Income in USD
    -172 Million USD
    Annual Results for Period Ending
    Sep-2022 ending year
    Headquarters Country
    Company Profile

    Bio-pharmaceutical company with headquarters is in California, USA.

  6. Chinook Therapeutics Inc.

    World Rank (Jan-05-2024)
    3,888
    Market Cap (Jan-05-2024)
    3.500 Billion USD
    World Rank (Jul-30-2023)
    4,787
    Market Cap (Jul-30-2023)
    2.609 Billion USD
    World Rank (Dec-25-2022)
    6,021
    Market Cap (Dec-25-2022)
    1.699 Billion USD
    World Rank (Jan-07-2022)
    10,625
    Market Cap (Jan-07-2022)
    0.81 Billion USD
    Annual Revenue in USD
    6 Million USD
    Annual Operating Income in USD
    -173 Million USD
    Annual Net Income in USD
    -187 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile

    Chinook Therapeutics, Inc. is a Clinical Stage Biopharmaceutical company discovering, developing and commercializing precision medicines for rare, severe chronic kidney diseases. The headquarters is in USA.

    Novartis acquired Chinook Therapeutics Inc. for 3.5 billion USD in 2023.

    Facts About Company

    Chinook Therapeutics, Inc. Annual Total Revenue for year ending Dec-2022 was 6 million USD and and Net loss for year ending Dec-2022 was -187 million USD.

    Chinook Therapeutics, Inc. Annual Total Revenue for year ending Dec-2021 was 51 million USD and and Net loss for year ending Dec-2021 was -102 million USD.

    As on 2022, Chinook Therapeutics, Inc. has 214 employees.

  7. Xenon Pharmaceuticals

    World Rank (Jan-05-2024)
    3,922
    Market Cap (Jan-05-2024)
    3.464 Billion USD
    World Rank (Jul-30-2023)
    5,199
    Market Cap (Jul-30-2023)
    2.331 Billion USD
    World Rank (Dec-25-2022)
    4,829
    Market Cap (Dec-25-2022)
    2.382 Billion USD
    World Rank (Jan-07-2022)
    7,271
    Market Cap (Jan-07-2022)
    1.57 Billion USD
    Annual Revenue in USD
    32 Million USD
    Annual Net Income in USD
    -28 Million USD
    Annual Results for Period Ending
    Dec-2020 ending year
    Headquarters Country
    Company Profile
    Xenon Pharmaceuticals is a clinical stage biopharmaceutical company committed to developing innovative therapeutics to improve the lives of patients with neurological disorders. The headquarters is in Canada.
  8. GW Pharmaceuticals

    World Rank (Jan-05-2024)
    3,962
    World Rank (Jul-30-2023)
    3,962
    World Rank (Dec-25-2022)
    3,962
    World Rank (Jan-07-2022)
    3,962
    Annual Revenue in USD
    527 Million USD
    Annual Net Income in USD
    -58 Million USD
    Annual Results for Period Ending
    Dec-2020 ending year
    Headquarters Country
    Company Profile

    GW Pharmaceuticals is a position in the development of plant derived cannabinoid therapeutics through it proven drug discovery and development processes intellectual property portfolio and regulatory and manufacturing expertise. The headquarters is in UK.

  9. MoonLake Immunotherapeutics

    World Rank (Jan-05-2024)
    3,968
    Market Cap (Jan-05-2024)
    3.404 Billion USD
    World Rank (Jul-30-2023)
    4,196
    Market Cap (Jul-30-2023)
    3.164 Billion USD
    World Rank (Dec-25-2022)
    14,035
    Market Cap (Dec-25-2022)
    0.390 Billion USD
    Headquarters Country
    Company Profile
    MOONLAKE IMMUNOTHERAPEUTICS is a clinical stage biopharmaceutical company with the novel investigational Nanobody for the treatment of inflammation to revolutionize outcomes for patients. The headquarters is in Switzerland.
  10. HUTCHMED (China) Limited

    World Rank (Jan-05-2024)
    4,247
    Market Cap (Jan-05-2024)
    3.124 Billion USD
    Headquarters Country
    Company Profile

    HUTCHMED is an innovative, commercial-stage biopharmaceutical company and developing targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The headquarters is in Hong Kong.

Share

Ads